This dual action distinguishes tirzepatide from single GLP-1 receptor agonists and contributes to its efficacy in glycaemic control and weight reduction
A 2025 study published in JAMA Network Open found that most patients with obesity discontinue GLP-1 therapy within a year, particularly those without type 2 diabetes 1
When inhaled, it may lead to swelling of the mouth, runny nose, drowsiness, or chest tightness
Our innovative approach combines cutting-edge weight management solutions with an unwavering commitment to your needs
Markvicka INTEGRATION OF EXCITATION-EMISSION SPECTROSCOPY WITH NEURAL NETWORKS FOR THE IDENTIFICATION OF PATHOGENIC BACTERIA Cody Schappert University of Nebraska at Omaha Rapid and reliable identification of pathogenic bacteria is critical to effectively prevent disease outbreaks and protect public health, yet many conventional diagnostic methods require an extensive amount of time, resources, experience, or a combination thereof